| Market Cap | ₹80Cr |
| ROE | 2.22% |
| P/E Ratio(TTM) | 50.77 |
| EPS(TTM) | 5.08 |
| P/B Ratio | 1.13 |
| Dividend Yield | 0.39% |
| Industry P/E | 40.22 |
| Book Value | 228.74 |
| Debt to Equity | 0.15 |
| Face Value | 10 |
| Parent Organisation | Samrat Pharmachem Limited |
| Managing Director | Lalit Mehta |
| Founded | 1992 |
| BSE Symbol | 530125 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.66 | ||
| Neuland Laboratories | NA (0.00%) | 85.89 | ||
| Jubilant Pharmova | NA (0.00%) | 36.43 | ||
| Acutaas Chemicals | NA (0.00%) | 60.38 |